Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Securitas Virtual Investor Day – Tuesday December 7 – Save the date

Securitas is pleased to invite investors, analysts and financial media to our Virtual Investor Day on Tuesday  December 7, 2021, at 14.00 CET to approx. 17.00. The event will provide a strategic and financial update, including status and achievements of our transformation programs and our intelligent security services journey.A formal invitation including the program will follow closer to the event.   Further information:  Investors: Micaela Sjökvist, Head of Investor Relations, mobile: +46 (0) 76 116 7443; micaela.sjokvist@securitas.comMedia: Helena Andreas, SVP Communications &

Slättö and SIBS forms a SEK 9bn joint venture to build 4,000 sustainability certified apartments in the Nordics

Slättö Förvaltning AB (“Slättö”), a leading manager of alternative investment funds, and SIBS AB (publ), one of the fastest growing home builders in the Nordic region (“SIBS”), today announces a letter of intent to form a Joint Venture between Slättö’s new fund Slättö Value Add II (“SVAII”) and SIBS to develop more than 4,000 apartments from SIBS’ project portfolio.The JV will, to begin with, acquire and develop SIBS’s existing portfolio of wholly owned building rights with a total property value upon completion of approx. SEK 9bn, distributed over 15 projects. Construction will commence

SmartCraft ASA (SMCRT) – Reminder: Invitation to presentation of second quarter and first half-year results 2021

SmartCraft ASA | Half yearly financial reports and audit reports / limited reviews23 August 2021 – REMINDER: SmartCraft ASA will publish its first half-year and second quarter 2021 financial report on Tuesday 24 August 2021 at 07:00 CEST together with the Q2 2021 presentation material on the company web site and onwww.newsweb.no. Investors, analysts and journalists are welcome to join to an English language webcast presentation of the report on the same day, Tuesday 24 August 2021, at 08:00 CEST. Webcast link:https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210824_5

Announcement from Embracer Group’s extra general meeting

The extra general meeting of Embracer Group AB (“Embracer” or the “Company”) was held today on 23 August 2021, through postal voting only, and the following resolutions were passed by the meeting.Authorization for the board to issue shares, convertibles and/or warrants The extra general meeting resolved, in accordance with the board of directors’ proposal, to authorize the board of directors during the period up until the next annual general meeting to, on one or more occasions, resolve to issue B shares, convertibles and/or warrants with right to convert into and subscribe for B shares

New Viking Glory to offer conferences with panoramic views of the world’s most beautiful archipelago

Viking Line’s new flagship, Viking Glory, to be launched in service in early 2022, will offer conference facilities in an unbeatable setting. The conference venue, which can accommodate nearly 400 conference guests, will offer panoramic views of the Baltic Sea from Deck 9. Conferences on board the vessel can be booked starting August 23, 2021.The shipping company Viking Line is now building Viking Glory, which will be one of the world’s most climate-smart vessels. Viking Glory will depart every evening from  Stockholm and sail via Mariehamn to Turku, Finland starting in early 2022. It will

Free Small Drink* at Tim Hortons ® Cookstown Restaurant and Drive Thru

Tim Hortons[®], the iconic Canadian coffee chain, has announced a limited time offer of a free small drink* from 8am-11pm every day until Sunday 5[th] September, exclusively at their Cookstown restaurant, located on Killymoon St.All guests are being welcomed to take part in the offer that lasts for fourteen nights, whether that’s through the drive thru, takeaway or restaurant dine in. Any small drink, excluding bottled drinks, will be included in the offer. From Canada’s Favourite French Vanilla, the creamy and cosy warmer, to the zingy Frozen Lemonade, and sweet tooth’s choice, the

Brighter's subsidiary Nectarine Health granted two U.S. patents

Brighter AB (publ) announced today that its subsidiary, Nectarine Health, has been granted two patents by the United States Patent and Trademark Office (USPTO) relating to the AI-driven Nectarine Health™ at Home care system. The first patent, Fall Detection System and Method (patent number US 11 069 213), relates to a fall detection method which is based on comparing measurements of ambient pressure. For example, when an individual wears the Nectarine Health™ at Home wristband, the technology will monitor for any deviations from the reference ambient pressure in the room. This patent has

Publication of promising preclinical data on FG001s effect in treatment of cancer

Copenhagen, Denmark, 23 August 2021. FluoGuide A/S ("FluoGuide" or the “Company”) is pleased to announce the first publication of preclinical data where the Company’s compound FG001 is used as a photothermal therapy agent for treatment of cancer. The new feature of FG001 complements the surgical targeting and opens new opportunities for the realization of clinical and commercial potential of the Company’s uPAR-targeting technology platform.Earlier this year the Company announced it had acquired worldwide exclusive rights to use FG001 for photothermal therapy. Now the first preclinical study

BioStock: Stayble Therapeutics CEO sums up Q2 and looks ahead

During the second quarter, Stayble Therapeutics focused primarily on the recruitment of patients to the ongoing phase IIb study with the injection treatment STA363. In addition, key employees have been recruited to the company and a high presence has been maintained towards potential partners. In an interview with BioStock, Stayble Therapeutics’ CEO Andreas Gerward talks about the most important events of the second quarter and the company’s plans for the autumn.Read the full article at biostock.se:  https://www.biostock.se/en/2021/08/stayble-therapeutics-ceo-sums-up-q2-and-looks-ahead/

Press release 2021-08-23 AcuCort to present at events arranged by Aktiespararna

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the company’s CEO Jonas Jönmark will participate and present at a number of events arranged by the Swedish Aktiespararna.The agenda and further details regarding the events, as well as details on accessing the digital events, will be made available on the Aktiespararna’s website . The presentations will be recorded and will be available following the conclusion of the events on AcuCort’s website, at the IR section . AcuCort to present at the

Major shareholder announcement

Company announcement 20/2021 With reference to company announcement no. 19 dated 20 August 2021, and in accordance with section 30 of the Capital Markets Act, HusCompagniet A/S (the “Company”) hereby announces that PFA Holding A/S has notified the Company that PFA Holding A/S indirectly through PFA Pension Forsikringsaktieselskab and PFA Asset Management has increased its voting rights in the Company. Voting rights PFA Asset Management has on 19 August 2021 increased its number of voting rights in the Company. PFA Asset Management may exercise voting rights in the Company of 5.90% (

Interim report January – June 2021

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 188 per share, compared with SEK 153 per share at the start of the year. This is an increase of 25.4 per cent. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) increased by 22.4 per cent. The net asset value was SEK 197 per share at 20 August.[1] · The total return on the Latour share was 42.3 per cent during the period measured against the SIXRX, which rose 22.4 per cent. INDUSTRIAL OPERATIONS The second quarter · The industrial operations' order intake rose 61 per cent to SEK

Valmet to deliver key pulp technology to Nine Dragons’ new Beihai mill in China

Valmet Oyj’s press release on August 23, 2021 at 9:00 a.m. EETValmet has received several pulp technology orders from Nine Dragons for their pulp, paper and board greenfield project in Beihai city, Guangxi autonomous region, in China. The order consists of two complete fiberlines, two bleached chemi thermo mechanical pulp (BCTMP) lines, a recovery boiler and DeNOx scrubbers. The deliveries will be done in phases and the start-ups are scheduled for 2023. The value of the order will not be disclosed. However, a project of this size and scope is typically valued at around EUR 140 million.

DISPENDIX welcomes Petros Apostolopoulos as new CEO to strengthen position as leading liquid handling and lab automation company

Effective August 2, 2021, Petros Apostolopoulos, who has a strong track record of launching high-tech products for Life Science automation, has taken over operations.DISPENDIX , a BICO  company, announces the appointment of Petros Apostolopoulos as the new company CEO. Petros will lead product, growth, market expansion and overall business operations and will continue to drive the strategy and focus of DISPENDIX to deliver customer success. Before joining DISPENDIX, Petros served over 15 years at Festo, a global leader in automation technology,

Nitro Games Oyj: Half-Year Report January – June 2021

Reporting period January – June 2021•    Revenues (Jan - Jun): 435,4 KEUR (984,7 KEUR on corresponding period 2020).•    EBITDA: -1 547,9 KEUR (-629,8 KEUR).•    EBIT: -1 848,5 KEUR (-858,1 KEUR). •    Net result: -1 856,8 KEUR (-870,1 KEUR).•    Earnings per share (EPS) -0,2 EUR / share (-0,1 EUR/ share).•    Cash and cash equivalents: 4 625,6 KEUR (30 June 2021). April – June 2021•    Revenues (Apr - Jun): 269,5 KEUR (523,0 KEUR on corresponding period 2020).•    EBITDA: -635,9 KEUR (-420,5 KEUR).•    EBIT: -767,7 KEUR (-534,7 KEUR). •    Net result: -770,6 KEUR (-

Episurf Medical hires Patrick Jamnik to head US business

Episurf Medical (NASDAQ: EPIS B) today announces its hiring of Patrick Jamnik as President of Episurf Medical Inc. In this newly created role, Mr Jamnik will be responsible for all US activities as Episurf Medical continues its international expansion. A veteran of both Stryker and Zimmer-Biomet, Mr Jamnik has extensive experience spanning over 16 years building and commercialising businesses across multiple orthopaedic disciplines in both Europe and the US. In a previous role, Mr Jamnik served as Global Marketing Director at Stanmore Implants, a venture-backed United Kingdom-based

SAS presents traffic program for the fall

As demand for both leisure and business travel increases, SAS continues to expand the number of flights. SAS will be flying more than 160 direct routes to 90 destinations during this fall.SAS increases the flights between the Scandinavian capitals and important destinations in its network to further improve connectivity for travelers. SAS will now be serving all its domestic destinations in Norway and Sweden when the Arlanda-Sundsvall route is reopened in September. In addition, the number of flights to important destinations for travelers in Europe will increase. The rising interest in

InDex Pharmaceuticals strengthens the clinical development organization in preparation of the start of the phase III study CONCLUDE with cobitolimod

August 23, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that two new employees have been appointed in the clinical development organisation in preparation of the start of the phase III study CONCLUDE with cobitolimod.Anders Bröijersén is joining InDex as Senior Medical Director Clinical Operations and Johan Levin as Project Manager Clinical Operations. Anders Bröijersén is a medical doctor and PhD with 15 years of experience in Clinical Development, Medical Affairs and Drug Safety at leading pharmaceutical companies such as Boehringer Ingelheim and MSD. Anders joins

Embellence Group Interim Report Q2 2021

Demand continues to increaseSecond quarter 2021 · Net sales amounted to MSEK 160.0 (120.4), up 32.9% · Organic growth of 21.1% · Adjusted EBITA amounted to MSEK 22.9 (16.7), up 37.1% · EBITA amounted to MSEK 21.2 (16.3), up 30.1% · Net profit for the period amounted to MSEK 13.3 (12.5) and earnings per share before dilution for the period were SEK 0.62 (0.58) · Operating cash flow amounted to MSEK 17.8 (29.2) Significant events during the quarter · New CEO of Wall&decò: Christian Tomadini · Launch of Boråstapeter’s digital flagship store, with its own e-

Liia Nõu appointed new CEO of Pandox

Pandox AB’s (publ) board of directors has appointed Liia Nõu as CEO. Liia Nõu has been Pandox’s CFO since 2007 and acting CEO since 21 May 2021.”Following a structured recruitment process and careful consideration, the board of directors is very pleased to appoint Liia Nõu as CEO of Pandox. Liia Nõu is a modern leader with a long experience from the hotel property market and a person, which both the board of directors and the organisation have great confidence in. The board of directors’ assessment is that Liia Nõu is the best person to balance Pandox’s need of both continuity and change”,

NILAR INTERIM REPORT Q2 2021

CONTINUED STRONG MARKET DEMAND - THE QUARTER AFFECTED BY PRODUCTION DISTURBANCIES April – June 2021 in summary · Revenue 7.2 (7.5) MSEK. · Production 3.3 MWh. · Delivered energy storages 220 (136), average size per energy storage 7 (12) kWh. · Gross profit -84.8 (-39.7) MSEK. · EBITDA -100.6 (-48.5) MSEK. · Operating income (EBIT) -118.7 (-63.1) MSEK. · Net loss -134.7 (-86.0) MSEK. · Earnings per share before/after dilution -4.03 SEK. January – June 2021 in summary · Revenue 12.6 (12.1) MSEK. · Production 6.5 MWh. · Delivered energy storages 293 (

Bulten extends existing FSP contract

Bulten is strengthening an existing FSP (Full Service Provider) contract for the supply of fasteners, with a further order from a European automotive manufacturer. The order is worth approximately SEK 68 million per annum. Deliveries are estimated to start in the fourth quarter of 2021, will reach full pace in 2022, and will run for three years.“The award of further products for an already established FSP contract confirms that our industry-leading position as a full-service provider of fasteners in the automotive industry, along with our responsiveness to customers’ requests, creates new

COVID-19 Phase II clinical trial initiated to evaluate ABNCoV2 as a booster vaccine

Hørsholm, Denmark, August 23, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a Phase II clinical trial to evaluate the ABNCoV2 capsid virus-like particle (cVLP) based COVID-19 vaccine has been initiated by Bavarian Nordic. The trial will investigate the potential of ABNCoV2 as a booster vaccine for individuals with previous COVID-19 disease or vaccination. Initial trial results are expected in the second half of 2021.The trial will enroll 150 healthy adults with existing immunity against SARS-CoV-2, acquired through previous

Photocure to Participate in Nordea’s Annual Small & Mid Cap Days 2021 Investor Conference

Press Release – Oslo, Norway August 23, 2021, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients,  announces that President and Chief Executive Officer, Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present a corporate overview and participate in meetings with investors at the Nordea Annual Small & Mid Cap Days 2021 conference to be held virtually August 24-26, 2021.Presentation Details · Photocure Presentation: Tuesday, August 24[th] at 3:25pm CET (9:25am EST) ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top